578 related articles for article (PubMed ID: 15031985)
1. [Gene therapy for muscular dystrophy].
Takeda S
No To Hattatsu; 2004 Mar; 36(2):117-23. PubMed ID: 15031985
[TBL] [Abstract][Full Text] [Related]
2. [Current status and perspective of gene therapy on dystrophic animal model].
Takeda S
Rinsho Shinkeigaku; 2004 Nov; 44(11):911-3. PubMed ID: 15651329
[TBL] [Abstract][Full Text] [Related]
3. Adeno-associated virus vector-mediated gene transfer into dystrophin-deficient skeletal muscles evokes enhanced immune response against the transgene product.
Yuasa K; Sakamoto M; Miyagoe-Suzuki Y; Tanouchi A; Yamamoto H; Li J; Chamberlain JS; Xiao X; Takeda S
Gene Ther; 2002 Dec; 9(23):1576-88. PubMed ID: 12424610
[TBL] [Abstract][Full Text] [Related]
4. AAV vector-mediated microdystrophin expression in a relatively small percentage of mdx myofibers improved the mdx phenotype.
Yoshimura M; Sakamoto M; Ikemoto M; Mochizuki Y; Yuasa K; Miyagoe-Suzuki Y; Takeda S
Mol Ther; 2004 Nov; 10(5):821-8. PubMed ID: 15509500
[TBL] [Abstract][Full Text] [Related]
5. Adeno-associated virus vector gene transfer and sarcolemmal expression of a 144 kDa micro-dystrophin effectively restores the dystrophin-associated protein complex and inhibits myofibre degeneration in nude/mdx mice.
Fabb SA; Wells DJ; Serpente P; Dickson G
Hum Mol Genet; 2002 Apr; 11(7):733-41. PubMed ID: 11929846
[TBL] [Abstract][Full Text] [Related]
6. Stable micro-dystrophin gene transfer using an integrating adeno-retroviral hybrid vector ameliorates the dystrophic pathology in mdx mouse muscle.
Roberts ML; Wells DJ; Graham IR; Fabb SA; Hill VJ; Duisit G; Yuasa K; Takeda S; Cosset FL; Dickson G
Hum Mol Genet; 2002 Jul; 11(15):1719-30. PubMed ID: 12095914
[TBL] [Abstract][Full Text] [Related]
7. Dual AAV therapy ameliorates exercise-induced muscle injury and functional ischemia in murine models of Duchenne muscular dystrophy.
Zhang Y; Yue Y; Li L; Hakim CH; Zhang K; Thomas GD; Duan D
Hum Mol Genet; 2013 Sep; 22(18):3720-9. PubMed ID: 23681067
[TBL] [Abstract][Full Text] [Related]
8. Antisense pre-treatment increases gene therapy efficacy in dystrophic muscles.
Peccate C; Mollard A; Le Hir M; Julien L; McClorey G; Jarmin S; Le Heron A; Dickson G; Benkhelifa-Ziyyat S; Piétri-Rouxel F; Wood MJ; Voit T; Lorain S
Hum Mol Genet; 2016 Aug; 25(16):3555-3563. PubMed ID: 27378686
[TBL] [Abstract][Full Text] [Related]
9. AAV-mediated overexpression of human α7 integrin leads to histological and functional improvement in dystrophic mice.
Heller KN; Montgomery CL; Janssen PM; Clark KR; Mendell JR; Rodino-Klapac LR
Mol Ther; 2013 Mar; 21(3):520-5. PubMed ID: 23319059
[TBL] [Abstract][Full Text] [Related]
10. Triple trans-splicing adeno-associated virus vectors capable of transferring the coding sequence for full-length dystrophin protein into dystrophic mice.
Koo T; Popplewell L; Athanasopoulos T; Dickson G
Hum Gene Ther; 2014 Feb; 25(2):98-108. PubMed ID: 24191945
[TBL] [Abstract][Full Text] [Related]
11. Adeno-associated virus vector-mediated minidystrophin gene therapy improves dystrophic muscle contractile function in mdx mice.
Watchko J; O'Day T; Wang B; Zhou L; Tang Y; Li J; Xiao X
Hum Gene Ther; 2002 Aug; 13(12):1451-60. PubMed ID: 12215266
[TBL] [Abstract][Full Text] [Related]
12. Long-term effect of human mini-dystrophin in transgenic mdx mice improves muscle physiological function.
Chu X; Li J; Qiao C; Wang J; Wang Y; Jiang XC; You H; Xiao X; Wang B
FASEB J; 2021 Jun; 35(6):e21628. PubMed ID: 33982338
[TBL] [Abstract][Full Text] [Related]
13. A translational approach for limb vascular delivery of the micro-dystrophin gene without high volume or high pressure for treatment of Duchenne muscular dystrophy.
Rodino-Klapac LR; Janssen PM; Montgomery CL; Coley BD; Chicoine LG; Clark KR; Mendell JR
J Transl Med; 2007 Sep; 5():45. PubMed ID: 17892583
[TBL] [Abstract][Full Text] [Related]
14. Adeno-associated virus vector carrying human minidystrophin genes effectively ameliorates muscular dystrophy in mdx mouse model.
Wang B; Li J; Xiao X
Proc Natl Acad Sci U S A; 2000 Dec; 97(25):13714-9. PubMed ID: 11095710
[TBL] [Abstract][Full Text] [Related]
15. Autotransplantation in mdx mice of mdx myoblasts genetically corrected by an HSV-1 amplicon vector.
Bujold M; Caron N; Camiran G; Mukherjee S; Allen PD; Tremblay JP; Wang Y
Cell Transplant; 2002; 11(8):759-67. PubMed ID: 12588108
[TBL] [Abstract][Full Text] [Related]
16. Delivery of AAV2/9-microdystrophin genes incorporating helix 1 of the coiled-coil motif in the C-terminal domain of dystrophin improves muscle pathology and restores the level of α1-syntrophin and α-dystrobrevin in skeletal muscles of mdx mice.
Koo T; Malerba A; Athanasopoulos T; Trollet C; Boldrin L; Ferry A; Popplewell L; Foster H; Foster K; Dickson G
Hum Gene Ther; 2011 Nov; 22(11):1379-88. PubMed ID: 21453126
[TBL] [Abstract][Full Text] [Related]
17. Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy.
Duan D
Mol Ther; 2018 Oct; 26(10):2337-2356. PubMed ID: 30093306
[TBL] [Abstract][Full Text] [Related]
18. Micro-dystrophin cDNA ameliorates dystrophic phenotypes when introduced into mdx mice as a transgene.
Sakamoto M; Yuasa K; Yoshimura M; Yokota T; Ikemoto T; Suzuki M; Dickson G; Miyagoe-Suzuki Y; Takeda S
Biochem Biophys Res Commun; 2002 May; 293(4):1265-72. PubMed ID: 12054513
[TBL] [Abstract][Full Text] [Related]
19. Full-length dystrophin reconstitution with adeno-associated viral vectors.
Lostal W; Kodippili K; Yue Y; Duan D
Hum Gene Ther; 2014 Jun; 25(6):552-62. PubMed ID: 24580018
[TBL] [Abstract][Full Text] [Related]
20. Codon optimization of the microdystrophin gene for Duchene muscular dystrophy gene therapy.
Athanasopoulos T; Foster H; Foster K; Dickson G
Methods Mol Biol; 2011; 709():21-37. PubMed ID: 21194019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
